Related Experiment Video
Updated: Feb 21, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Progression of Duchenne Cardiomyopathy Presenting with Chest Pain and Troponin Elevation
Kan N Hor1, Pace Johnston1, Kathi Kinnett2
1Nationwide Children's Hospital, Columbus, OH, USA.
Insights
Acute chest pain with elevated troponin I (cTn) in Duchenne muscular dystrophy (DMD) boys may signal worsening cardiomyopathy. This under-recognized presentation indicates acute left ventricular dysfunction and myocardial fibrosis progression in DMD patients.
Area of Science:
- Cardiology
- Neuromuscular Disorders
- Biomarkers
Background:
- Duchenne muscular dystrophy (DMD) management advances have shifted mortality causes to progressive cardiomyopathy.
- Troponin I (cTn) levels are typically not elevated in asymptomatic DMD patients despite cardiac imaging findings.
Purpose of the Study:
- To describe the clinical presentation and cardiac findings in Duchenne muscular dystrophy (DMD) boys experiencing acute chest pain (ACP) with elevated troponin I (cTn).
- To investigate the association between ACP, cTn elevation, and cardiomyopathy progression in DMD.
Main Methods:
- Case series of eight boys with DMD presenting with acute chest pain (ACP) and elevated troponin I (cTn).
- Evaluation included electrocardiograms (ECG), cardiac magnetic resonance imaging (CMR) with late gadolinium enhancement (LGE), and serial cTn measurements.
- Left ventricular ejection fraction (LVEF) was assessed via echocardiography and CMR.
Main Results:
- Eight DMD boys presented with ACP and acute cTn elevation (mean peak 44±15.4 ng/mL).
- CMR revealed increased LGE (12.4% to 36.5%) and decreased LVEF (61% to 47.6%), which remained depressed on follow-up.
- cTn levels normalized with supportive care; viral studies were negative.
Conclusions:
- Acute chest pain (ACP) with troponin I (cTn) elevation is a recognized clinical event in Duchenne muscular dystrophy (DMD) boys.
- This presentation signifies acute left ventricular dysfunction and potential progression of myocardial fibrosis, indicating cardiomyopathy advancement.
- These events may represent a critical pathophysiological mechanism in DMD cardiomyopathy progression.
Background:
Improved neuromuscular and respiratory therapies have altered the natural history of Duchenne muscular dystrophy (DMD) such that the most common cause of mortality is progressive cardiomyopathy. Despite imaging evidence of progressive cardiomyopathy, troponin I (cTn) is not significantly elevated in asymptomatic DMD patients.
Results:
We describe eight boys with DMD evaluated for acute chest pain (ACP) and found to have acute cTn elevation with depressed left ventricular ejection fraction (LVEF). Of our eight patients, five presented with a primary complaint of ACP, while three presented with secondary myocardial injury in the context of systemic illness requiring hospitalization. Electrocardiograms showed diffuse ST changes and mean peak cTn level was 44±15.4 ng/mL (reference range <0.03 ng/mL). cTn levels normalized with only supportive care. Cardiac magnetic resonance imaging (CMR) was performed during the event on all but one patient, demonstrating increased late gadolinium enhancement (LGE) from 12.4±11.4% to 36.5±10.3% with associated deterioration of LVEF from 61±4.4% to 47.6±6.6% which remained depressed on follow-up CMR study (49.1±7.8%). All viral studies were negative. Additional investigations varied among patients, but no causative findings were demonstrated.
Conclusions:
ACP with cTn elevation occurs in DMD boys and may be indicative of cardiomyopathy progression as evidenced by acute left ventricular dysfunction and development or progression of myocardial fibrosis. This clinical presentation is under recognized. These events may represent an important pathophysiological mechanism in cardiomyopathy progression.
More Related Videos
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome III: Diagnostic Studies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pericarditis II: Clinical Features and Diagnostic Tests
Coronary Artery Disease III: Clinical Manifestations

